Albanian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Faqja 1 nga 112 rezultatet
Genetic make-up modifies cancer outcome
Vetëm përdoruesit e regjistruar mund të përkthejnë artikuj
Identifikohuni Regjistrohu
TECHNICAL FIELD OF THE INVENTION
This invention is related to the area of cancer. In particular, it relates to genetic factors that modify outcome.
BACKGROUND OF THE INVENTION
Follicular epithelial cell-derived thyroid cancer is the most common endocrine malignancy with a high incidence worldwide
Anti-inflammatory agent and cancer-preventive agent comprising canolol or prodrug thereof and pharmaceutical, cosmetic and food comprising the same
Vetëm përdoruesit e regjistruar mund të përkthejnë artikuj
Identifikohuni Regjistrohu
BACKGROUND ART
An anti-inflammatory agent is a substance that suppresses inflammatory cytokines and/or inflammatory mediators (such as prostaglandins). Aspirin and teprenone are known examples of anti-inflammatory agents.
A cancer-preventive agent is a substance that prevents carcinogenesis induced
Thermotherapy method for treatment and prevention of cancer in male and female patients and cosmetic ablation of tissue
Vetëm përdoruesit e regjistruar mund të përkthejnë artikuj
Identifikohuni Regjistrohu
BACKGROUND OF THE INVENTION
The present invention generally relates to a minimally invasive method for administering focused energy, such as adaptive microwave phased array or single applicator hyperthermia, to treat ductal and glandular carcinomas and intraductal hyperplasia, as well as benign
Organoselenium compounds for cancer chemoprevention
Vetëm përdoruesit e regjistruar mund të përkthejnë artikuj
Identifikohuni Regjistrohu
BACKGROUND OF THE INVENTION
Cancer incidence and mortality have not declined at the same rate as other major causes of death. This suggests that primary prevention, including the use of chemopreventative agents, is a valuable approach to decreasing mortality, as it avoids all the potential
Organoselenium compounds for cancer chemoprevention
Vetëm përdoruesit e regjistruar mund të përkthejnë artikuj
Identifikohuni Regjistrohu
BACKGROUND OF THE INVENTION
Cancer incidence and mortality have not declined at the same rate as other major causes of death. This suggests that primary prevention, including the use of chemopreventative agents, is a valuable approach to decreasing mortality, as it avoids all the potential
Organoselenium compounds for cancer chemoprevention
Vetëm përdoruesit e regjistruar mund të përkthejnë artikuj
Identifikohuni Regjistrohu
BACKGROUND OF THE INVENTION
Cancer incidence and mortality have not declined at the same rate as other major causes of death. This suggests that primary prevention, including the use of chemopreventative agents, is a valuable approach to decreasing mortality, as it avoids all the potential
Organoselenium compound for cancer chemoprevention
Vetëm përdoruesit e regjistruar mund të përkthejnë artikuj
Identifikohuni Regjistrohu
BACKGROUND OF THE INVENTION
Cancer incidence and mortality have not declined at the same rate as other major causes of death. This suggests that primary prevention, including the use of chemopreventative agents, is a valuable approach to decreasing mortality, as it avoids all the potential
Halofuginol derivatives and their use in cosmetic and pharmaceutical compositions
Vetëm përdoruesit e regjistruar mund të përkthejnë artikuj
Identifikohuni Regjistrohu
BACKGROUND OF THE INVENTION
Halofuginone is a halogenated derivative of febrifugine, a natural product extracted from the roots of the hydrangea Dichroa febrifuga. Dichroa febrifuga is one of the "fifty fundamental herbs" of traditional Chinese medicine, originally used as an anti-malarial remedy
New derivatives of 5,6,7,8-tetrahydro-1-naphthalenol, a process for their preparation and cosmetic and pharmaceutical compositions containing them
Vetëm përdoruesit e regjistruar mund të përkthejnë artikuj
Identifikohuni Regjistrohu
The present invention relates to new derivatives of 5,6,7,8-tetrahydro-1-naphthalenol, a process for their preparation and their use as antioxidants in cosmetic compositions and in pharmaceutical compositions for the preventative treatment of cutaneous inflammations and allergies or certain forms of
Cosmetic and pharmaceutical compositions containing naphthalenol derivatives
Vetëm përdoruesit e regjistruar mund të përkthejnë artikuj
Identifikohuni Regjistrohu
The present invention relates to new derivatives of 5,6,7,8-tetrahydro-1-naphthalenol, a process for their preparation and their use as antioxidants in cosmetic compositions and in pharmaceutical compositions for the preventative treatment of cutaneous inflammations and allergies or certain forms of
Method of reducing cancer cell proliferation by administering recombinant alpha-fetoprotein
Vetëm përdoruesit e regjistruar mund të përkthejnë artikuj
Identifikohuni Regjistrohu
SEQUENCE LISTING
This application contains a sequence listing which is provided as a computer readable format as well as a PDF-format which is identical with the contents of the computer readable version.
FIELD OF INVENTION
The invention relates to the microbiological and medical industry, genetic
Pharmaceutical, cosmetic and/or food composition with antioxidant properties
Vetëm përdoruesit e regjistruar mund të përkthejnë artikuj
Identifikohuni Regjistrohu
OBJECT OF THE INVENTION
The present invention relates to a pharmaceutical, cosmetic and/or foodstuff composition intended in particular for the prevention and/or treatment of diseases associated with pro-oxidizing agents.
The present invention also relates to the use of the pharmaceutical, cosmetic
Tert-butyl derivatives of benzylidenecamphor, process for preparing them, their use as antioxidant agents and cosmetic and pharmaceutical compositions containing them
Vetëm përdoruesit e regjistruar mund të përkthejnë artikuj
Identifikohuni Regjistrohu
The present invention relates to new tert-butyl derivatives of benzylidenecamphor, to a process for preparing them and to their uses as antioxidant agents as well as in cosmetic compositions for daily use or for protection against sunlight and in pharmaceutical compositions for the preventive
Compounds useful in therapeutic and cosmetic methods
Vetëm përdoruesit e regjistruar mund të përkthejnë artikuj
Identifikohuni Regjistrohu
This application claims the benefits under 35 U.S.C. 119(a)-(d) or (b), or 365(b) of International Application No. PCT/IB2008/055272 filed Dec. 12, 2008; European Application No. 07123268.0 filed Dec. 14, 2007; and Swiss Application No. 1040/08 filed Jul. 4, 2008.
TECHNICAL FIELD
The present
Heterocyclic compounds for cancer chemoprevention
Vetëm përdoruesit e regjistruar mund të përkthejnë artikuj
Identifikohuni Regjistrohu
BACKGROUND OF THE INVENTION
Chemoprevention is the use of chemicals to prevent the occurrence and/or the progression of cancer. Numerous naturally occurring and synthetic compounds have been found to protect laboratory animals from chemically induced tumorigenesis. A few of the promising ones are on
Baza e të dhënave më e plotë e bimëve medicinale e mbështetur nga shkenca
- Punon në 55 gjuhë
- Kurime bimore të mbështetura nga shkenca
- Njohja e bimëve nga imazhi
- Harta GPS interaktive - etiketoni bimët në vendndodhje (së shpejti)
- Lexoni botime shkencore në lidhje me kërkimin tuaj
- Kërkoni bimë medicinale nga efektet e tyre
- Organizoni interesat tuaja dhe qëndroni në azhurnim me kërkimet e lajmeve, provat klinike dhe patentat
Shkruani një simptomë ose një sëmundje dhe lexoni në lidhje me barërat që mund të ndihmojnë, shtypni një barishte dhe shikoni sëmundjet dhe simptomat që përdoren kundër.
* I gjithë informacioni bazohet në kërkimin shkencor të botuar
